INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $214,000 | +18.2% | 95,332 | +80.4% | 0.00% | 0.0% |
| Q3 2021 | $181,000 | -38.9% | 52,859 | -46.7% | 0.00% | 0.0% |
| Q2 2021 | $296,000 | +516.7% | 99,116 | +320.7% | 0.00% | 0.0% |
| Q4 2017 | $48,000 | -68.8% | 23,560 | -79.6% | 0.00% | -66.7% |
| Q3 2017 | $154,000 | +600.0% | 115,760 | +719.5% | 0.00% | – |
| Q2 2017 | $22,000 | -70.3% | 14,126 | -74.2% | 0.00% | -100.0% |
| Q4 2016 | $74,000 | +155.2% | 54,830 | +196.4% | 0.00% | +50.0% |
| Q3 2016 | $29,000 | -50.0% | 18,500 | -57.7% | 0.00% | -50.0% |
| Q2 2016 | $58,000 | -83.6% | 43,690 | -34.9% | 0.00% | -85.2% |
| Q1 2016 | $354,000 | -16.3% | 67,100 | +24.5% | 0.03% | -41.3% |
| Q4 2015 | $423,000 | +271.1% | 53,900 | +418.3% | 0.05% | +24.3% |
| Q2 2015 | $114,000 | – | 10,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |